BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

887 related articles for article (PubMed ID: 10541552)

  • 21. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
    O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
    Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
    Bertwistle D; Sherr CJ
    Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
    Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
    Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice.
    Baxter EW; Blyth K; Cameron ER; Neil JC
    J Virol; 2001 Oct; 75(20):9790-8. PubMed ID: 11559812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc.
    Datta A; Nag A; Pan W; Hay N; Gartel AL; Colamonici O; Mori Y; Raychaudhuri P
    J Biol Chem; 2004 Aug; 279(35):36698-707. PubMed ID: 15199070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
    Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W
    Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.
    Zindy F; Eischen CM; Randle DH; Kamijo T; Cleveland JL; Sherr CJ; Roussel MF
    Genes Dev; 1998 Aug; 12(15):2424-33. PubMed ID: 9694806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of p14ARF overcomes tumor resistance to p53.
    Lu W; Lin J; Chen J
    Cancer Res; 2002 Mar; 62(5):1305-10. PubMed ID: 11888896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
    Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
    Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.
    Macias E; Jin A; Deisenroth C; Bhat K; Mao H; Lindström MS; Zhang Y
    Cancer Cell; 2010 Sep; 18(3):231-43. PubMed ID: 20832751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
    Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G
    Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma.
    Riley MF; You MJ; Multani AS; Lozano G
    Oncogene; 2016 Jan; 35(3):358-65. PubMed ID: 25915849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
    Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3.
    Petrenko O; Li J; Cimica V; Mena-Taboada P; Shin HY; D'Amico S; Reich NC
    PLoS One; 2021; 16(3):e0247394. PubMed ID: 33651821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
    Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
    Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleolar Arf sequesters Mdm2 and activates p53.
    Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
    Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.